Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin (SAIL)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by University of Manitoba
Sponsor:
Collaborator:
Novo Nordisk A/S
Information provided by (Responsible Party):
Dr. Vincent Woo, University of Manitoba
ClinicalTrials.gov Identifier:
NCT01628445
First received: June 21, 2012
Last updated: July 31, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)